Literature DB >> 2266458

Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores.

I N Soomro1, W F Whimster.   

Abstract

Estimation of the growth fraction with the use of monoclonal antibody Ki67, which recognizes a nuclear antigen in proliferating cells, was compared with the nucleolar organizer region staining in 95 lung tumours. There was nuclear staining in most tumours; 12 tumours were negative. Cytoplasmic staining was observed in another seven tumours. The small cell carcinoma group had the highest mean Ki67 index (23.75); squamous carcinomas had a mean value of 15.71, adenocarcinomas 10.99, and large cell anaplastic 20.76. Carcinoids had few stained cells. Nucleolar organizer regions were demonstrated by the argyrophilic method (AgNOR). No correlation was found between Ki67 indices and AgNOR scores. Kinetic data obtained by the AgNOR technique were less discriminating in view of the overlap between scores of various groups including carcinoids. We conclude that use of the monoclonal antibody Ki67 is a more reliable method of assessing proliferative activity in lung tumours. This antibody may be effective in identifying slowly proliferating tumours which are less sensitive to chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266458     DOI: 10.1002/path.1711620307

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

Authors:  H Kitamura; Y Kameda; N Nakamura; Y Nakatani; Y Inayama; M Iida; K Noda; N Ogawa; T Shibagaki; M Kanisawa
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

2.  Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.

Authors:  G Fontanini; R Pingitore; D Bigini; S Vignati; S Pepe; A Ruggiero; P Macchiarini
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

3.  An application of MIB antibody to the retrospective study of melanomas of oral mucosa and facial skin.

Authors:  M Korabiowska; U Brinck; J F Hoenig; S B Bartkowski; J Mirecka; A Schauer
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer.

Authors:  Nicola Ciancio; Maria Grazia Galasso; Raffaele Campisi; Laura Bivona; Marcello Migliore; Giuseppe U Di Maria
Journal:  Multidiscip Respir Med       Date:  2012-09-14

5.  An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.

Authors:  L G Bobrow; F R Hirsch; F G Hay; L Happerfield; B G Skov; K Law; R C Leonard; R L Souhami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

Review 6.  Digging deeper into volatile organic compounds associated with cancer.

Authors:  Sajjad Janfaza; Babak Khorsand; Maryam Nikkhah; Javad Zahiri
Journal:  Biol Methods Protoc       Date:  2019-11-27

7.  Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.

Authors:  M M Tinnemans; B Schutte; M H Lenders; G P Ten Velde; F C Ramaekers; G H Blijham
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

8.  Proliferative activity (ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases.

Authors:  R Jong; A M Davis; M G Mendes; J S Wunder; R S Bell; R Kandel
Journal:  Sarcoma       Date:  2000

9.  Ki-67 labeling index affects tumor infiltration patterns of lung squamous cell carcinoma.

Authors:  Daisuke Masuda; Ryota Masuda; Tomohiko Matsuzaki; Naoko Imamura; Naohiro Aruga; Makiko Tanaka; Sadaki Inokuchi; Hiroshi Kijima; Masayuki Iwazaki
Journal:  Mol Med Rep       Date:  2015-09-24       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.